Surgery in early (b)(6): (r) needle localization segmental mastectomy with placement of a biozorb tissue marker.This was seen in surgical clinic by partner and registered nurse practitioner (rnp) for hematoma.Follow-up and monitoring occurred in surgical clinic six, nineteen, and twenty two days later.Dehiscence of breast wound with partial evacuation of hematoma prompting take-back to the operating room (or) twenty six days post-mastectomy.Delay of initiation of chemotherapy by 5 days for breast wound fistula overlying the biozorb.Notation of protrusion of a fractured prong of the biozorb device through the breast wound between cycle 3 and 4 of 4 cycles of chemotherapy.Last chemo treatment occurred in early (b)(6).The removal of the defective biozorb device and resection of the wound and fistula and resection of the fat necrosis in the segmentectomy bed, occurred at the end of (b)(6).(27 days delay to allow for improvement in the immunosuppression and poor wound healing associated with chemotherapy.).
|